The bodies of Kfir and Ariel Bibas, the two youngest captives held by Hamas, were confirmed to be among those released as part of a ceasefire deal. However, the body that was believed to be their ...

This new logo streamlined Google's visual identity into something crisp and clean, making it easy to recognise at any size. It's like a fresh coat of paint on your front door; it makes a lasting ...

Umang Vohra to Nimura: "In the case of tariff barriers, generics companies are likely to be more selective, focusing on high-value opportunities including 'first to file'." The Managing Director ...

Cipla has recently fallen below its 20-day Exponential Moving Average, currently standing at a price of Rs 1460.3. Today, it has experienced a change of -1.11%, with the 20-day EMA noted at 1460.34.

Try this new app before you start sacrificing files. It turns out the Mac has this ability to reclaim disk space without actually deleting files in some instances. If you’re a programmer like ...

The real-life Pickles — Portland’s collegiate summer league baseball team — have criticized Disney and Pixar for allegedly using their trademarks without ... and their logo and uniforms ...

The U.K. announced a major boost in the country's military spending ahead of Prime Minister Starmer's meeting with President Trump. The Atlantic staff writer Anne Applebaum joins Katy Tur to ...

This system employs Raman fiber amplifier with bidirectional pumping in conjunction with a bidirectional EDFA, without the use of in-line relay amplifier. Through an analysis of the interference light ...

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

Cipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib capsules in 50 mg, 150 mg, and 200 mg strengths. The oral ...

Cipla has received final approval from the US Food and Drug Administration (FDA) for its New Drug Application (NDA) for Nilotinib Capsules in 50 mg, 150 mg, and 200 mg dosages. Nilotinib is indicated ...

Lupin Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., and Zydus Lidesciences Ltd. delivered strong revenue and profit growth in the December quarter, beating analyst expectations, and are the ...